President Biden signs COVID-19 pandemic relief legislation
X

President Biden signs COVID-19 pandemic relief legislation

March 11, 2021


On March 11, 2021, President Joe Biden signed the $1.9 trillion COVID-19 pandemic relief package.  “The American Rescue Plan Act of 2021” (HR 1319) will provide both economic and health care assistance to millions of Americans. 

Below is a summary of the legislative package as it relates to health care. 

Aid to State and Local Governments

  • Provides $350 billion to help states and local governments cover increased expenditures, replenish lost revenue and mitigate economic harm from the COVID-19 pandemic through December 31, 2024.  Funding can be used to help small business physician practices.

$92 billion for COVID-19 Public Health Services and Provider Assistance

  • $8.5 billion to the CARES Act Provider Relief Fund for rural providers.
  • $12.7 billion to the CDC for vaccine distribution.
  • $48 billion for testing, contact tracing and personal protective equipment (PPE).
  • $7.6 billion for state/local public health departments to bolster the public health workforce.
  • $7.6 billion for community health centers to serve underserved communities of color.
  • $6.5 billion for Substance Abuse and Mental Health Services.
  • $200 million to support COVID-19 infection control in skilled nursing facilities.  

Small Business Assistance

  • $15 billion in new funding for targeted economic injury disaster loan (EIDL) small business grants.
  • Numerous extensions of tax credits and other tax clarifications.

Medicaid (Medi-Cal) Funding

  • Requires state Medicaid programs to cover vaccines and COVID treatment without any cost sharing until one year after the end of the public health emergency.
  • Increases the federal Medicaid assistance percentage (FMAP) matching funds to 100% for vaccine costs during this period.
  • Provides a five-year state plan option of health coverage for women enrolled in Medicaid for 12 months after the birth of a child.
  • Outpatient drugs used for COVID-19 treatment must be included in the Medicaid drug rebate program.
  • Starting in 2024, eliminates the cap on the drug rebate amount that pharmaceutical manufacturers are required to pay Medicaid for covered drugs, increasing the rebates owed to Medicaid.
  • Increases federal matching funds for several programs within Medicaid.

ACA and COBRA Coverage Funding Assistance

  • Subsidizes 100% of COBRA insurance premiums through September 30, 2021, for individuals who lost their jobs or had reduced hours. Employers or health plans may also claim a refundable tax credit against their Medicare payroll tax liability for the cost of the premiums.
  • Provides nearly $35 billion in refundable tax credits and premium assistance for those enrolled in Affordable Care Act (ACA) Exchange health plans (Covered California) for two years as follows: 
    • Expands the ACA refundable tax credits for individuals above 400% of the federal poverty level (FPL) – ~$50,000 for an individual – flattening the ACA Subsidy “cliff.” Caps premium costs at 8.5% of income.
    • Eliminates ACA insurance premiums for those individuals between 100%-150% of FPL.
    • Increases the ACA premium subsidy for those individuals between 150%-400% of FPL.
    • Provides $20 million in HHS grants to states to modernize ACA exchanges.

For more information, see CMA's Executive Summary. 

 

Was this article helpful?    
Download the New CMADocs app!

Download the new CMADocs app!

CMA's new mobile app lets you connect with your colleagues and engage with CMA content!  Download the "CMADocs" app today from the Apple or Google Play app stores for daily news updates, events calendar, resource library and more.

Latest News

Load More